Best Telehealth Clinics in Rhode Island (2026)
Compare TRT, GLP-1, HRT, hair loss, and ED clinics available in Rhode Island. True annual cost — labs and startup fees included.
Testosterone (TRT) in Rhode Island
See all Testosterone (TRT) clinics →GLP-1 Weight Loss in Rhode Island
See all GLP-1 Weight Loss clinics →HRT in Rhode Island
See all HRT clinics →Sexual Health (ED) in Rhode Island
See all Sexual Health (ED) clinics →Telehealth in Rhode Island
Telehealth services in Rhode Island operate under state medical board regulations that require prescriptions from licensed physicians based on proper diagnostic evaluation. All clinics listed on ClinicLayer are licensed to practice in Rhode Island or work with Rhode Island-licensed physicians.
Most telehealth programs ship medication directly to your Rhode Island address within 5–7 business days of prescription approval. No in-person visits required.
Telehealth laws in Rhode Island
Rhode Island's telehealth framework is governed by RI General Laws Chapter 27-81 (the Telemedicine Coverage Act) and Board of Medical Licensure guidelines. The Board requires an established in-person physician-patient relationship before prescribing controlled substances via telehealth. This is a Board-level rule, not just a statutory provision.
A covering physician may prescribe controlled substances for a short duration under an existing coverage agreement, but this exception is narrow. Online-questionnaire-only prescribing is prohibited. The in-person requirement is the primary barrier for telehealth-only controlled substance platforms.
Rhode Island passed IMLC legislation, but implementation has been delayed. The state is not yet an operationally active IMLC member as of April 2026. Providers must obtain a standard Rhode Island medical license.
Rhode Island is a full practice authority state for nurse practitioners. NPs can prescribe independently, including controlled substances.
Rhode Island Medicaid GLP-1 coverage for obesity is uncertain. The state has appeared on some lists of covering states but is not consistently confirmed. Verify current coverage with Rhode Island Medicaid directly.
Rhode Island has a progressive income tax with a top rate of 5.99%. The state sales tax is 7% but prescription drugs are exempt.
Provider availability in Rhode Island
Rhode Island has 1.1 million residents. Provider availability for controlled substance telehealth is below average due to the in-person requirement and pending IMLC status. The small state size means a limited local provider pool.
All-50-state providers like Maximus ($100/mo) and Hone Health ($25/mo) serve Rhode Island. TRT Nation ($99/mo) includes RI. These platforms must have workflows to satisfy the in-person requirement. BraverX ($129/mo), PeterMD ($99/mo), and DudeMeds ($77/mo) generally list RI.
GLP-1 availability is unrestricted. All national GLP-1 providers serve Rhode Island. Medicaid GLP-1 obesity coverage is uncertain.
All HRT, hair loss, and ED providers with national coverage serve Rhode Island for non-controlled medications. No known provider exclusions for RI.
Cost comparison in Rhode Island
TRT pricing: DudeMeds $77/mo ($1,124/year), TRT Nation $99/mo ($1,446/year), PeterMD $99/mo ($1,188/year), Maximus $100/mo ($1,300/year), BraverX $129/mo ($1,548/year). The in-person requirement may add indirect costs.
GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. Rhode Island Medicaid GLP-1 obesity coverage is uncertain — verify directly.
Rhode Island does not tax prescription medications. The state sales tax is 7% but Rx drugs are exempt. Rhode Island has a progressive income tax with a top rate of 5.99%.
HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo). ED: Hims $17/mo to MEDVi $119/mo.
Regulations by treatment type in Rhode Island
TRT (testosterone replacement therapy)
Rhode Island's Board of Medical Licensure requires an established in-person relationship for controlled substance prescribing via telehealth. The federal DEA waiver may override this through 2026, but state compliance risk remains. Full NP practice authority. IMLC pending. Both compounded and FDA-approved testosterone available.
GLP-1 weight loss
No state-specific GLP-1 restrictions. Federal FDA compounding rules apply. Medicaid obesity coverage is uncertain.
HRT (hormone replacement therapy)
HRT follows standard federal prescribing rules in Rhode Island. No additional state restrictions.
Hair loss
Hair loss treatment follows standard federal prescribing rules. No additional state restrictions.
ED (erectile dysfunction)
ED treatment follows standard federal prescribing rules. No additional state restrictions.
Peptides
Controlled peptides are subject to the in-person requirement. Non-controlled peptides follow standard federal rules.